RE:RE:RE:RE:The voteEh, I still it's simply that the company technology is simply not as "exciting" as they had hoped. They ran on fumes for years (moneywise) hoping someone would buy into their platform and act as the white knight. In the end, no one really came forward. Prothena passed. Chiesi did nothing and no one else was left standing to save them. They had no money, no progress with their pipeline in all of these years so MTP, an unimpressive company figured they could buy them for very cheap and perhaps find some thing useful with their platform. Essentially they are buying it for almost nothing. MTP isn't exactly a big player in the pharma space so for them, that may be all MTP could afford. I just don't know what the employees/management did all of these years to earn a salary? Maybe that should be investigated? Have Dr. Rath tell us what exactly she did each day/month/year for the company. It does not seem like anything at all was done in years except the ceo teasing shareholders they had so many irons in the fire. In the end, they had nothing going on.